Exploring the determinants of treatment success for tuberculosis cases in Europe

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 11, 2005, Pages 1224-1229

  Falzon, Dennis ^a   Le Strat, Y ^a   Belghiti, F ^a   Infuso, A ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Europe; Multivariate analysis; Surveillance; Treatment outcome; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRIA; CHILD; CONFIDENCE INTERVAL; DATA ANALYSIS; DISEASE PREDISPOSITION; DRUG RESISTANCE; ESTONIA; EUROPE; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; ICELAND; LOGISTIC REGRESSION ANALYSIS; MALE; NETHERLANDS; NORWAY; PATIENT CARE; PRIORITY JOURNAL; ROMANIA; SLOVAKIA; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REMISSION INDUCTION; TUBERCULOSIS, PULMONARY;

EID: 28444448440     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. World Health Organization. 44th World Health Assembly: resolutions and decisions. Resolution WHA 44.8. WHA44/1991/REC/1. Geneva, Switzerland: WHO, 1991.
2. World Health Organization. Tuberculosis Programme. Frame-work for effective Tuberculosis Control. WHO/TB/94.179. Geneva, Switzerland: WHO, 1994.
3. World Health Organization. Global Tuberculosis Programme. Global Tuberculosis Control. WHO Report. WHO/TB/97.225. Geneva, Switzerland: WHO, 1997.
4. Veen J, Raviglione M, Rieder H L, et al. Standardised tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the WHO and European Region of IUATLD for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998; 12: 505-510.
5. EuroTB (InVS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2001. Saint-Maurice, France: Institut de Veille Sanitaire, December 2003.
6. Rieder H, Kelly G D, Block A B, Cauthen G M, Snider D E. Tuberculosis diagnosed at death in the United States. Chest 1991; 100: 678-811.
7. National Centre for Health Statistics. Acquired immunodeficiency syndrome (AIDS) cases, according to age at diagnosis, sex, detailed race, and Hispanic origin: United States, selected years 1985-2002. Atlanta, GA: Centers for Disease Control and Prevention, 2003. www.cdc.gov/nchs/data/hus/tables/2003/ 03hus053.pdf Accessed December 2004.
8. Balasubramanian R, Garg R, Santha T, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004; 8: 323-332.
9. Connolly C, Davies G R, Wilkinson D. Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa. Int J Tuberc Lung Dis 1999; 3: 1081-1087.
10. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan P J, McAdam K P. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718.
11. Coker R. Multi-drug resistant tuberculosis: public health challenges. Trop Med Int Health 2004; 9: 25-40.
12. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No 3. Prevalence and trends. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.